Page 7 - Pharma Companies

Pricing pressure in US market to impact margins of pharma companies

Lack of new launches due to inspection delays, intensifying competition key headwinds

Morepen Laboratories rallies 17% in two days on fundraising plans

Morepen Laboratories board approved the issue of up to 5 crore equity shares to Liquid Holdings, an entity belonging to the promoter group of the company, at a price of Rs 38 per equity share

Private sector looking to pool demand for Covid vaccines procurement

Private sector in India is looking to pool their demand for effective procurement of vaccines to ensure uninterrupted access to the lifesaving vaccines, healthcare and industry federations said

Prioritise country first, PM Modi tells Covid-19 vaccine makers

"He has asked the industry to prioritise deliveries to meet the country's needs first and then focus on global supplies," said a person in the know, who did not wish to be named.

Covid-19: Remdesivir output to be doubled to 7.4 mn doses by April-end

18 new sites get DCGI consent to make antiviral used for treating Covid-19

Covid-19 vaccination: Too early to say if booster dose needed, say experts

Pfizer CEO has said a 3rd booster shot likely within a year of vaccination

The supply side

Ramping up vaccine availability has become critical

Dr Reddy's to also use govt cold chain infra for Sputnik V distribution

The vaccine would be transported in frozen form by air and road

Dr Reddy's to submit more data on Covid-19 vaccine Sputnik V by July

Colour-coded doses will have two different antigens

The second wave: Pharma stocks make a comeback as Covid-19 cases rise

However, analysts say these stocks may not deliver bumper returns like last year

Covid-19 vaccine: Real-world data to decide commercial marketing approval

Two such vaccines are Covishield, made by the Serum Institute of India (SII), and Covaxin by Bharat Biotech

J&J in talks with Centre for trial of single-shot Covid-19 vaccine

Russia's Sputnik V is another contender to get approval from the Indian drug regulator

Govt asks drug makers to ramp up remdesivir production to full capacity

The government on Wednesday said that all seven manufacturers of remdesivir in the country have been asked to ramp up production to full capacity by next week.

Biocon partners with Libbs Farmaceutica to launch generic drugs in Brazil

Biotechnology major Biocon on Monday said its subsidiary has joined hands with Libbs Farmaceutica to launch generic drugs in Brazil, the world's sixth most populous country.

Status check of PLI schemes that aim to make India world's factory

Last year, the govt introduced a PLI scheme for mobile phones, electronic components, critical pharma drugs and medical devices, which saw huge traction among global as well as Indian manufacturers

Natco Pharma's board approves acquiring 1% in its Canadian subsidiary

Drug major Natco Pharma on Friday said its board has approved acquiring about 1 per cent stake in its Canadian subsidiary

Will supply more doses of AstraZeneca vaccine to UK later, says Serum

Senior officials in New Delhi confirmed that there was no ban on exports from India, and no plans to do so either.

PE/VC investments gather pace in February: Here're the top 5 deals

The top 10 investments accounted for 69 per cent of the total deal value, according to Aurum Equity Partners

India emerges global manufacturing hub for Covid-19 vaccine Sputnik V

Gland Pharma to make 252 mn doses, Hetero 100 mn doses, Strides may also join the fray

Four IPOs get investors' backing; chemical firm and jeweler make their mark

Anupam Rasayan's Rs 760-crore offer was subscribed 45 times; Kalyan Jewellers' IPO was subscribed 60 per cent on the first day of the issue